Related Experiment Videos
[Reactive thrombocytosis in infants and children (author's transl)]
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|December 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
Counselling for HIV-positive haemophiliacs in Japan.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics.
Haemophilia : the official journal of the World Federation of Hemophilia·2013
Paediatric presentation and outcome of congenital protein C deficiency in Japan.
Haemophilia : the official journal of the World Federation of Hemophilia·2013
Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd report.
Haemophilia : the official journal of the World Federation of Hemophilia·2012
An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.
Haemophilia : the official journal of the World Federation of Hemophilia·2011
[Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Complement-coagulation crosstalk in immunothrombosis].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026